Stay updated with breaking news from Optic pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tovorafenib elicited rapid, clinically meaningful tumor responses in pediatric patients with low-grade gliomas, including those with optic pathway gliomas, regardless of prior MAPK inhibitor status. ....